What this is
Single filing record
This page shows the rows from one Form 4 filing as reported to the SEC.
Big buy
Charles Cherington: large open-market buy of ERNA
$2M open-market purchase by Charles Cherington, 10% Owner at Ernexa Therapeutics Inc, filed February 18, 2026. Learn more
Feed status Last SEC check:Loading Last Filing: Loading
View ERNA
Access Free feed
Quick read What does this view show?
Why it matters
Read the SEC filing
The original SEC document is the source record. Always verify before drawing conclusions.
How to read it
Role, size, timing
Insider activity carries more weight from senior officers, large dollar values, and clustered timing.
Stacked feeds
Key insider views at a glance
Big BuyERNA
$4.35-4.81% today
Charles Cherington · 10% Owner at Ernexa Therapeutics Inc
$2M
Charles Cherington bought $2M of ERNA (Ernexa Therapeutics Inc).
Insider purchase
Transaction details
Charles Cherington, a 10% beneficial owner, reported a $2M open-market purchase equal to 43% of ERNA's market cap.
Charles Cherington (10% Owner) bought 4,000,000 shares of ERNA, Ernexa Therapeutics Inc, Healthcare ($4.7M market cap), at $0.50 per share on February 10, 2026 for a total of $2M (43% of the market cap).
Charles Cherington
10% Owner
Purchase value$2M
Shares purchased4,000,000
Price per share$0.50 per share
- % of market cap
- 43%
- Trade date
- February 10, 2026
- Filed
- February 18, 2026
- Filing delay
- 8 days
Permalink https://bluecollarpicks.com/insider-trading/ERNA/buy/2070698
Market context
ERNA market snapshot
Current price$4.35
1-day change-4.81%
Market cap$4.7M
SectorHealthcare
Next earningsNovember 5, 2026
$4.35
Current price$4.35
Analyst target$0.00 (0.0%)
Last enriched September 2, 2026 at 7:30 AM EDT.
Filings
Recent insider trades
Status Loading
Latest visible filing loading.
Public Form 4 filings, normalized for cleaner scanning. What do these codes mean?
| Ticker | Type & Role | Value | |
|---|---|---|---|
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Grant Director | $0 | ||
Buy 10% Owner | Not reported | ||
| This filing | Big Buy 10% Owner | $2M | |
Big Buy 10% Owner | $2.2M | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Sell 10% Owner | Not reported | ||
Sell 10% Owner | Not reported | ||
Sell 10% Owner | Not reported | ||
Sell 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | Not reported | ||
Buy 10% Owner | $394.2K | ||
Grant Director
$0
Grant Director
Grant Director
$0
Grant Director
Not reported
Buy 10% Owner
Big Buy 10% Owner
$2.2M
Big Buy 10% Owner
Not reported
Buy 10% Owner
Not reported
Buy 10% Owner
Not reported
Buy 10% Owner
Not reported
Buy 10% Owner
Not reported
Sell 10% Owner
Not reported
Sell 10% Owner
Not reported
Sell 10% Owner
Not reported
Sell 10% Owner
Not reported
Buy 10% Owner
Not reported
Buy 10% Owner
$394.2K
Buy 10% Owner
Cluster detail
Cluster members
Ticker context
Ticker summary
Recent insider activity for this company.
Insider detail
Insider activity
Recent transactions grouped by reporting owner.
Filters
Filters
Weekly recap
Get the easier version in your inbox.
Start with the free weekly recap. Upgrade later if you want the paid daily brief.
Free weekly recap. No login required. Unsubscribe any time.
Method Public Form 4 filings, normalized for cleaner scanning. Filtered rows stay available in All Form 4 Filings and ticker history. Which view should I use? →
Paid research tools
CSV exports are becoming a paid feature.
Join the waitlist for founding-member access to CSV exports, saved screens, and premium download tools when they open.